Full Name
Kam Man Hui
Variants
HUI, KAM MAN
Hui, K.M.
HUI, KAM M.
Hui, K.
 
 
 
Email
gmshkm@nus.edu.sg
 
 

Refined By:
Date Issued:  [2000 TO 2023]

Results 1-20 of 20 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
12017A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinomaDai X.; Wang L. ; Deivasigamni A.; Looi C.Y.; Karthikeyan C.; Trivedi P.; Chinnathambi A.; Alharbi S.A.; Arfuso F.; Dharmarajan A.; Goh B.C. ; Hui K.M. ; Kumar A.P. ; Mustafa M.R.; Sethi G. 
215-Feb-2014A paper-based microfluidic electrochemical immunodevice integrated with amplification-by-polymerization for the ultrasensitive multiplexed detection of cancer biomarkersWu, Y.; Xue, P.; Hui, K.M. ; Kang, Y.
32017An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemiaHer Z.; Yong K.S.M.; Paramasivam K.; Tan W.W.S.; Chan X.Y.; Tan S.Y.; Liu M. ; Fan Y.; Linn Y.C. ; Hui K.M. ; Surana U. ; Chen Q. 
41-Jul-2013Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human gliomaYulyana, Y.; Endaya, B.B.; Ng, W.H.; Guo, C.M.; Hui, K.M. ; Lam, P.Y.P.; Ho, I.A.W.
52004Characterization of a novel IRF-1-deficient mutant cell lineLim, S.P. ; Hui, K.M. 
62015ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinomaChen Jianxiang; Xia Hongping; Zhang Xiaoqian; Karthik Sekar; Pratap S.V.; Ooi London L.; Hong Wankin; Hui Kam Man 
727-Sep-2021Epigenetic derepression converts PPAR gamma into a druggable target in triple-negative and endocrine-resistant breast cancersLoo, Ser Yue; Syn, Nicholas L; Koh, Angele Pei-Fern ; Teng, Janet Cheng-Fei ; Deivasigamani, Amudha; Tan, Tuan Zea ; Thike, Aye Aye ; Vali, Shireen ; Kapoor, Shweta; Wang, Xiaoyuan ; Wang, Jiong Wei ; Tan, Puay Hoon ; Yip, George W ; Sethi, Gautam ; Huang, Ruby Yun-Ju ; Hui, Kam Man ; Wang, Lingzhi ; Goh, Boon Cher ; Kumar, Alan Prem 
8Jan-2013Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesisHo, I.A.W.; Toh, H.C.; Ng, W.H.; Teo, Y.L.; Guo, C.M.; Hui, K.M. ; Lam, P.Y.P.
9Mar-2013Innovative evolution of cancer gene and cellular therapiesLam, P.; Khan, G.; Stripecke, R.; Hui, K.M. ; Kasahara, N.; Peng, K.-W.; Guinn, B.-A.
10Aug-2013MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancerXia, H.; Ooi, L.L.P.J.; Hui, K.M. 
11Nov-2012MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeuticsXia, H.; Hui, K.M. 
121-Jan-2018Molecular targets and anti-cancer potential of escinCheong, Dorothy HJ ; Arfuso, Frank; Sethi, Gautam ; Wang, Lingzhi ; Hui, Kam Man ; Kumar, Alan Prem ; Thai, Tran 
1317-Sep-2013Paper-based microfluidic electrochemical immunodevice integrated with nanobioprobes onto graphene film for ultrasensitive multiplexed detection of cancer biomarkersWu, Y.; Xue, P.; Kang, Y.; Hui, K.M. 
14Aug-2013Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse modelSia, K.C.; Huynh, H.; Chung, A.Y.F.; Ooi, L.L.P.J.; Lim, K.H.; Hui, K.M. ; Lam, P.Y.P.
152-Nov-2021PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)Thura, Min; Al-Aidaroos, Abdul Qader; Gupta, Abhishek ; Chee, Cheng Ean ; Lee, Soo Chin ; Hui, Kam Man ; Li, Jie; Guan, Yeoh Khay ; Yong, Wei Peng ; So, Jimmy; Chng, Wee Joo ; Ng, Chin Hin ; Zhou, Jianbiao ; Wang, Ling Zhi; Yuen, John Shyi Peng; Ho, Henry Sun Sien ; Yi, Sim Mei; Chiong, Edmund ; Choo, Su Pin ; Ngeow, Joanne; Ng, Matthew Chau Hsien ; Chua, Clarinda; Yeo, Eugene Shen Ann ; Tan, Iain Bee Huat ; Sng, Joel Xuan En; Tan, Nicholas Yan Zhi; Thiery, Jean Paul ; Goh, Boon Cher ; Zeng, Qi 
162019Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient PopulationsTeo, W.-Y.; Sekar, K.; Seshachalam, P.; Shen, J.; Chow, W.-Y.; Lau, C.C.; Yang, H.K.; Park, J.; Kang, S.-G.; Li, X.; Nam, D.-H.; Hui, K.M. 
17Nov-2013Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growthOng, H.-T.; Federspiel, M.J.; Guo, C.M.; Ooi, L.L.; Russell, S.J.; Peng, K.-W.; Hui, K.M. 
1831-Oct-2021Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathwayArora, Loukik; Mohan, Chakrabhavi Dhananjaya; Yang, Min Hee; Rangappa, Shobith; Deivasigamani, Amudha; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B.; Garg, Manoj; Chinnathambi, Arunachalam; Alharbi, Sulaiman Ali; Alahmadi, Tahani Awad; Rangappa, Kanchugarakoppal S.; Hui, Kam Man ; Sethi, Gautam ; Ahn, Kwang Seok
1915-Sep-2011Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinomaWang, S.M.; Ooi, L.L.P.J.; Hui, K.M. 
202014γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen, K.S.; Ahn, K.S.; Ong, T.H.; Shanmugam, M.K. ; Li, F.; Yap, W.N.; Kumar, A.P. ; Fong, C.W.; Tergaonkar, V.; Hui, K.M. ; Sethi, G.